Your browser doesn't support javascript.
loading
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders.
Juza, Radomir; Musilek, Kamil; Mezeiova, Eva; Soukup, Ondrej; Korabecny, Jan.
Affiliation
  • Juza R; Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.
  • Musilek K; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
  • Mezeiova E; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
  • Soukup O; Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Korabecny J; Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.
Med Res Rev ; 43(1): 55-211, 2023 01.
Article in En | MEDLINE | ID: mdl-36111795
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Receptors, Dopamine D2 Limits: Humans Language: En Journal: Med Res Rev Year: 2023 Document type: Article Affiliation country: Czech Republic Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Receptors, Dopamine D2 Limits: Humans Language: En Journal: Med Res Rev Year: 2023 Document type: Article Affiliation country: Czech Republic Country of publication: United States